ARID1A and central nervous system cancer: TK-RIG915 also demonstrated low RNA expression of the SWI/SNF complex component ARID1A. Inactivating mutations or reduced ARID1A expression is common in multiple cancer types including glioma where it is associated with poorer prognosis [76,77].